FDA advisers review SYD-101, low-dose atropine 0.01% for pediatric myopia, on Oct 30 after a 2025 complete response letter.
|Articles|May 2, 2022
BHVI announces Myopia Awareness Week 2022
Author(s)Alex Delaney-Gesing, Senior Editor
Set for May 23-28, the global initiative aims to bring attention to the global epidemic of myopia cases in children.
Advertisement
Included in this year’s week-long event are a range of educational resources for eye care practitioners (ECPs), parents, and advocates of
Social media content and prominent individuals within the global eye care field will also provide tips and recommendations for parents and children to reduce the risk of onset or progression of myopia.
Additional resources and information on the campaign can be found
Advertisement
Related to this article
Christina M. Danley, OD, FOVDR, explores the many nuances that require consideration when answering a common question asked by parents of children with myopia.
Magdalena Stec, OD, FAAO, and Noreen Shaikh, OD, MEd, FAAO, gave an overview of current evidence-based myopia control treatments in part of their AAOpt 2026 session.
Presenters from AAOpt26's research symposium share their findings, applications for optometric practice, and goals for future study.
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
Magdalena Stec, OD, FAAO; Noreen Shaikh, OD, FAAO; Huizi Kelly Yin, OD, FAAO; and Brenda Bohnsack, MD, PhD, detail their AAOpt 2026 session in Anaheim, California.
A handful of eye care providers spoke on the factors that have led to a lack of eye care access for World Sight Day.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: Current controversies in macular hole diagnosis, management
2
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
3
FDA approves subcutaneous Enspryng for TED
4
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
5